Innovation Engine
We have state-of-the-art technology and manufacturing
platforms to repeatedly innovate with speed
Antibody Discovery and Development
In-house capabilities from early discovery to GMP manufacturing
Vaccine Technology
Innovative and highly differentiated “personalized” and “off-the-shelf” vaccines
Adaptive Learning Platform Systems (ALPS)
Artificial Intelligence (AI) based R&D platform to expand new molecular targets for cancer therapy
GMP Manufacturing Facility
(Berkeley, CA and Lexington, MA)
A key driver of rapid development that helps us advance faster than our peers